Position in HIMS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$592,475
+$141,900 QoQ
Shares Held
17,089
-21.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#254
of 506 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $7,523,206 across 11 Drug Manufacturers - Specialty & Generic names. HIMS ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
24,414 | $1,754,390 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
46,085 | $1,561,359 | |
| 3 | VTRS |
Viatris Inc
|
92,472 | $1,468,455 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,355 | $734,179 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
This page
|
17,089 | $592,475 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
3,926 | $435,550 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
11,937 | $293,769 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
5,224 | $242,968 |
All Filings in HIMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $592,475 | 17,089 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $450,575 | 21,704 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $957,215 | 29,480 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,809,171 | 49,527 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,678,549 | 33,672 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $404,155 | 13,677 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $354,164 | 14,647 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||